Jonathan Scheiman
Seminars
Tuesday 24th June 2025
Panel Discussion: From Consumer Success to Clinical Impact: How Direct-to-Consumer Microbiome Products Are Shaping Therapeutic Breakthroughs
4:30 pm
- Evaluating clinical trial strategies for direct-to-consumer microbiome products: costs, regulatory pathways, and scientific credibility
- Analyzing the economic viability of trial-based models in the DTC space: profitability, investor interest, and commercialization speed
- Navigating marketing and regulatory constraints for microbiome therapeutics in a consumer-driven landscape
Wednesday 25th June 2025
Advancing Next-Generation Probiotics: Translating FitBiomics’ Clinical & Preclinical Data into Performance and Health Innovations
11:00 am
- Harnessing the Gut Microbiome for Human Performance – Exploring FitBiomics’ latest clinical and preclinical data on next-generation probiotics derived from elite athletes and their potential to enhance metabolism, endurance, and recovery
- Bridging the Gap Between Preclinical Insights and Clinical Validation – Lessons learned from translating microbiome-based discoveries into human trials, including biomarker-driven approaches to assess efficacy
- Mechanisms of Action: Understanding How Novel Probiotics Drive Health Benefits – Unpacking the functional impact of specific microbial strains on gut health, immune modulation, and systemic health improvements
- Regulatory & Commercialization Strategies for Microbiome-Based Interventions – Addressing the path from research to real-world applications, including regulatory considerations, consumer adoption, and future innovation in the probiotics space
